Acadia Pharmaceuticals | ACAD - 税引前利益





税引前利益 変化する 日付
Acadia Pharmaceuticals USD 26.32M 18.28M 2025-12
ALKERMES USD 100.74M 4.1M 2025-09
Alnylam Pharmaceuticals USD 161.14M 77.83M 2025-12
Biogen USD 557.3M 186.7M 2025-09
BioMarin Pharmaceutical USD -26.32M 324.19M 2025-09
Bristol-Myers Squibb USD 3.11B 1.34B 2025-09
Cara Therapeutics USD -4.91M 3.17M 2025-03
Corcept Therapeutics USD 15.24M 16.45M 2025-09
Cytokinetics USD -183.03M 123.15M 2025-12
Eisai JPY 22B 7.47B 2025-12
Eli Lilly USD 7.23B 456M 2025-09
Incyte USD 389.94M 92.37M 2025-12
J&J USD 4.97B 2.53B 2025-12
Moderna USD -187M 631M 2025-09
Neurocrine Biosciences USD 239.4M 52.4M 2025-12
Pfizer USD 3.33B 290M 2025-09
Prothena USD -21.58M 15.33M 2025-12
PTC Therapeutics USD -139.08M 116.01M 2025-12
Sarepta Therapeutics USD -407.67M 213.63M 2025-12
Ultragenyx Pharmaceutical USD -128M 51.54M 2025-12
Vanda Pharmaceuticals USD -22.92M 16.68M 2024-12
Vertex Pharmaceuticals USD 1.3B 15.8M 2025-09